Zyvidol Tablet is a combination pharmaceutical formulation containing Trypsin 48mg, Bromelain 90mg, Rutoside 100mg, and Diclofenac 50mg, designed for the management of inflammatory conditions and associated pain. Trypsin and Bromelain are proteolytic enzymes that facilitate the reduction of edema and inflammation by promoting the breakdown of proteinaceous debris at the site of injury, thereby enhancing tissue repair. Rutoside, a bioflavonoid, exhibits antioxidant properties and strengthens capillary walls, contributing to decreased vascular permeability and improved microcirculation. Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), provides potent analgesic and anti-inflammatory effects through inhibition of cyclooxygenase enzymes, reducing prostaglandin synthesis. The synergistic action of these components makes Zyvidol effective in the treatment of musculoskeletal disorders such as sprains, strains, postoperative swelling, and other inflammatory conditions. It is indicated for short-term use under medical supervision to alleviate pain, swelling, and inflammation. Caution is advised in patients with hypersensitivity to NSAIDs, bleeding disorders, or gastrointestinal ulcers. Zyvidol should be used as prescribed, with attention to contraindications and potential drug interactions, to ensure optimal therapeutic outcomes and minimize adverse effects.